The ubiquitin proteasome system and its involvement in cell death pathways

[1]  Amanda Doucette,et al.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer , 2009, Nature.

[2]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[3]  Aaron Ciechanover,et al.  The HECT family of E3 ubiquitin ligases: multiple players in cancer development. , 2008, Cancer cell.

[4]  A. Ciechanover,et al.  Itch: a HECT-type E3 ligase regulating immunity, skin and cancer , 2008, Cell Death and Differentiation.

[5]  K. Iwai,et al.  Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex. , 2006, Biochemical and biophysical research communications.

[6]  D. Parks,et al.  Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo , 2006, Molecular Cancer Therapeutics.

[7]  Hiroshi Yasui,et al.  A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. , 2005, Cancer cell.

[8]  I. Rose.  Ubiquitin at Fox Chase* , 2005, Cell Death and Differentiation.

[9]  G. Melino.  Discovery of the ubiquitin proteasome system and its involvement in apoptosis , 2005, Cell Death and Differentiation.

[10]  A. Ciechanover.  Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting* , 2005, Cell Death and Differentiation.

[11]  A. Hershko,et al.  The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle* , 2005, Cell Death and Differentiation.

[12]  Pankaj Oberoi,et al.  Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. , 2005, Cancer cell.

[13]  M. Protopopova,et al.  Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors , 2004, Nature Medicine.

[14]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[15]  J. Adams,et al.  Development of the Proteasome Inhibitor Velcade™ (Bortezomib) , 2004, Cancer investigation.

[16]  A. Varshavsky.  The N-end rule and regulation of apoptosis , 2003, Nature Cell Biology.

[17]  G. Melino.  The Sirens' song , 2001, Nature.

[18]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[19]  Lucjan T. Orłowski.  Exchange-rate policies in central Europe and monetary union , 1998 .

[20]  S. Ōmura,et al.  Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. , 1995, Biochemical and biophysical research communications.

[21]  Y. Shaul,et al.  Ubiquitin-independent p53 proteasomal degradation , 2010, Cell Death and Differentiation.

[22]  J. Marine,et al.  Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.

[23]  M. Pagano,et al.  Dissecting the role of ubiquitylation in the DNA damage response checkpoint in G2 , 2010, Cell Death and Differentiation.

[24]  S-C Sun.  CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes , 2010, Cell Death and Differentiation.

[25]  C. Day,et al.  Assembling the building blocks: structure and function of inhibitor of apoptosis proteins , 2010, Cell Death and Differentiation.

[26]  W. Gu,et al.  The multiple levels of regulation by p53 ubiquitination , 2010, Cell Death and Differentiation.

[27]  A. Bergmann.  The role of ubiquitylation for the control of cell death in Drosophila , 2010, Cell Death and Differentiation.

[28]  B. Yang,et al.  Nedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functions , 2010, Cell Death and Differentiation.

[29]  T. O'Brien,et al.  Therapeutic strategies within the ubiquitin proteasome system , 2010, Cell Death and Differentiation.

[30]  V. Dixit,et al.  Regulation of death receptor signaling by the ubiquitin system , 2010, Cell Death and Differentiation.

[31]  J. Silke,et al.  Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs , 2010, Cell Death and Differentiation.

[32]  C. Duckett,et al.  XIAP as a ubiquitin ligase in cellular signaling , 2010, Cell Death and Differentiation.

[33]  Aaron Ciechanover,et al.  Proteolysis: from the lysosome to ubiquitin and the proteasome , 2005, Nature Reviews Molecular Cell Biology.

[34]  A. Goldberg,et al.  Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.